Protalex Inc - Company & Market Research Reports

Protalex is a clinical-stage biopharmaceutical company focused on the development of drugs for treating autoimmune and inflammatory diseases including Rheumatoid Arthritis (RA) and Immune Thrombocytopenia (ITP). Protalex’s lead product, PRTX-100, is a formulation of a proprietary, highly purified form of Staphylococcal Protein A, which is an immunomodulatory protein produced by bacteria. The company was founded in 1999 and is based in Florham Park, New Jersey.

Rheumatoid Arthritis - Pipeline Review, H2 2017 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H2 2017

  • Drug Pipelines
  • 1051 Pages
From
Immune Thrombocytopenic Purpura Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments - Product Thumbnail Image

Immune Thrombocytopenic Purpura Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

  • Report
  • 88 Pages
From
Rheumatoid Arthritis - Pipeline Review, H1 2017 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H1 2017

  • Drug Pipelines
  • 1020 Pages
From
Rheumatoid Arthritis: Beyond TNF Inhibitors, 2016-2026 - Product Thumbnail Image

Rheumatoid Arthritis: Beyond TNF Inhibitors, 2016-2026

  • Report
  • 240 Pages
From
Thrombocytopenia - Market Insights, Epidemiology and Market Forecast-2027 - Product Thumbnail Image

Thrombocytopenia - Market Insights, Epidemiology and Market Forecast-2027

  • Drug Pipelines
  • 240 Pages
From
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H2 2018 - Product Thumbnail Image

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H2 2018

  • Drug Pipelines
  • 112 Pages
From
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2018 - Product Thumbnail Image

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2018

  • Drug Pipelines
  • 116 Pages
From
Thrombocytopenia - Pipeline Review, H2 2016 - Product Thumbnail Image

Thrombocytopenia - Pipeline Review, H2 2016

  • Drug Pipelines
  • 163 Pages
From
OpportunityAnalyzer: Immune Thrombocytopenia (ITP) - Opportunity Analysis and Forecasts to 2025 - Product Thumbnail Image

OpportunityAnalyzer: Immune Thrombocytopenia (ITP) - Opportunity Analysis and Forecasts to 2025

  • Drug Pipelines
  • 243 Pages
From
Idiopathic Thrombocytopenic Purpura - Pipeline Insight, 2018 - Product Thumbnail Image

Idiopathic Thrombocytopenic Purpura - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Global Musculoskeletal Disorders Therapeutics Market 2016-2020 - Product Thumbnail Image

Global Musculoskeletal Disorders Therapeutics Market 2016-2020

  • Report
  • 120 Pages
From
Myasthenia Gravis - Pipeline Review, H2 2018 - Product Thumbnail Image

Myasthenia Gravis - Pipeline Review, H2 2018

  • Drug Pipelines
  • 133 Pages
From
Thrombocytopenia - Pipeline Review, H1 2016 - Product Thumbnail Image

Thrombocytopenia - Pipeline Review, H1 2016

  • Drug Pipelines
  • 178 Pages
From
Thrombocytopenia Global Clinical Trials Review, H2, 2018 - Product Thumbnail Image

Thrombocytopenia Global Clinical Trials Review, H2, 2018

  • Clinical Trials
  • 442 Pages
From
Thrombocytopenia - Pipeline Review, H1 2015 - Product Thumbnail Image

Thrombocytopenia - Pipeline Review, H1 2015

  • Drug Pipelines
  • 188 Pages
From
Protalex Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

Protalex Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • 50 Pages
From
Protalex Inc (PRTX) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Protalex Inc (PRTX) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • 25 Pages
From
Protalex Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report - Product Thumbnail Image

Protalex Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

  • Financial Report
  • 35 Pages
From
Protalex Inc Strategic Analysis Review - Protalex Inc SWOT, Outlook, Operations and Financial Profile - Product Thumbnail Image

Protalex Inc Strategic Analysis Review - Protalex Inc SWOT, Outlook, Operations and Financial Profile

  • Company Profile
  • 30 Pages
From
Protalex, Inc. Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis - Product Thumbnail Image

Protalex, Inc. Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

  • Company Profile
  • 30 Pages
From
  • 20 Results (Page 1 of 1)
Loading Indicator
adroll